Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a phase I clinical study.
Barkholt L, Alici E, Conrad R, Sutlu T, Gilljam M, Stellan B, Christensson B, Guven H, Björkström NK, Söderdahl G, Cederlund K, Kimby E, Aschan J, Ringdén O, Ljunggren HG, Dilber MS.
Barkholt L, et al. Among authors: ljunggren hg.
Immunotherapy. 2009 Sep;1(5):753-64. doi: 10.2217/imt.09.47.
Immunotherapy. 2009.
PMID: 20636021
Clinical Trial.